Skip to main content
Top

Journal of Inherited Metabolic Disease

Issue 8/2003

Content (15 Articles)

Neonatal screening for cystic fibrosis: France rises to the challenge

J. P. Farriaux, M. Vidailhet, M. L. Briard, V. Belot, J. L. Dhondt

Glycine N-methyltransferase deficiency: A new patient with a novel mutation

P. Augoustides-Savvopoulou, Z. Luka, S. Karyda, S. P. Stabler, R. H. Allen, K. Patsiaoura, C. Wagner, S. H. Mudd

Homocystinuria due to cystathionine β-synthase deficiency: Novel biochemical findings and treatment efficacy

M. Orendáč, J. Zeman, S. P. Stabler, R. H. Allen, J. P. Kraus, O. Bodamer, S. Stöckler-Ipsiroglu, J. Kvasnička, V. Kožich

Niemann–Pick disease: Sixteen-year follow-up of allogeneic bone marrow transplantation in a type B variant

S. Victor, J. B. S. Coulter, G. T. N. Besley, I. Ellis, R. J. Desnick, E. H. Schuchman, A. Vellodi

Hearing loss in Fabry disease: The effect of agalsidase alfa replacement therapy

D. Hajioff, Y. Enever, R. Quiney, J. Zuckerman, K. Mackermot, A. Mehta

Markedly elevated serum biotinidase activity may indicate glycogen storage disease type Ia

B. Wolf, C. L. Freehauf, J. A. Thomas, P. L. Gordon, C. L. Greene, J. C. Ward

Molecular genetic analysis of glycogen storage disease type Ia in 26 Chinese patients

W. J. Qiu, X. F. Gu, J. Ye, L.Sh. Han, Y. F. Zhang, X. Q. Liu

Clinical heterogeneity in patients with mutations in the NDUFS4 gene of mitochondrial complex I

S. M. S. Budde, L. P. W. J. van den Heuvel, R. J. P. Smeets, D. Skladal, J. A. Mayr, C. Boelen, V. Petruzzella, S. Papa, J. A. M. Smeitink

Two novel mutations in the gene for human α-mannosidase that cause α-mannosidosis

T. Beccari, L. Bibi, R. Ricci, D. Antuzzi, A. Burgalossi, E. Costanzi, A. Orlacchio

Letter to the Editor

Letters to the Editor

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine